Day: July 6, 2020

Schlieren/Switzerland, 06 July 2020The news release can be downloaded from the following link: AttachmentRelease_06072020

CHICAGO, July 06, 2020 (GLOBE NEWSWIRE) — GATX Corporation (NYSE:GATX) announced that it will report results for the 2020 second quarter prior to market open on July 21, 2020. GATX will hold a conference call to review the results later that morning. Investors may listen to the call via telephone or over the internet as follows:Live TeleconferenceTo participate by phone, please dial in approximately 15 minutes prior to the start time and reference the GATX conference call. To listen via webcast, click the link on GATX’s homepage, www.gatx.com.Replay InformationCOMPANY DESCRIPTIONGATX Corporation (NYSE:GATX) strives to be recognized as the finest railcar leasing company in the world by our customers, our shareholders, our employees and the communities where we operate. As the leading global railcar lessor, GATX has been providing...

McLEAN, Va., July 06, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced that it has elected Allan P. Merrill and Paul T. Schumacher to its Board of Directors, effective September 1, 2020. Merrill is chairman, president and chief executive officer of Beazer Homes USA, Inc., a diversified national homebuilder. Schumacher is founder, president and chief executive officer of Schumacher Homes, Inc., one of the country’s leading custom homebuilders.“On behalf of Freddie Mac, we welcome Allan Merrill and Paul Schumacher to our Board of Directors,” said Freddie Mac Non-Executive Board Chair Sara Mathew. “Each brings important perspectives on critical aspects of the housing industry as well as considerable executive leadership and financial experience. Their insights will help us continue to deliver on our mission as we embark...

VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) wishes to amend its news release dated July 2, 2020 in which it announced a shares for debt transaction.Aggregate shares has been amended from 5,077,965 to 5,477,965 shares.Contact:Hector Bremner, CEO 604-773-8943info@avricorehealth.com www.avricorehealth.com About Avricore Health Inc.Avricore Health Inc. is committed to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. The Company’s goal is to empower consumers, patients and pharmacists with innovative technology, products, services and information to monitor and optimize health. www.avricorehealth.comNeither the TSX Venture Exchange nor its Regulation Services...

WINNIPEG, Manitoba, July 06, 2020 (GLOBE NEWSWIRE) — (TSX: NWC):  The North West Company Inc. (the “Company” or “North West”) announced today the closing of the sale of 36 Giant Tiger stores (the “GT Store Transaction”) to Giant Tiger Stores Limited (“GTSL”), effective July 5, 2020.The GT Store Transaction was completed on substantially the same terms previously reported by the Company over the past two quarters and which can be accessed in the investor section of the Company’s website at www.northwest.ca.“The GT Store Transaction enables North West to put more focus on our core business performance and potential, including our ongoing product supply arrangements with GTSL and our retained Giant Tiger stores serving northern communities. A special thank you to the great team of Giant Tiger store associates who have now joined the...

PHOENIX, July 06, 2020 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corporation (Nasdaq: WSC) today announced that it will release its second quarter 2020 financial results on Monday, August 10, 2020 before the markets open.Chief Executive Officer, Bradley Soultz, President and Chief Operating Officer, Kelly Williams and Chief Financial Officer, Timothy Boswell will host a conference call and webcast on Monday, August 10, 2020 at 10:00 a.m. EDT to discuss the results.The live call can be accessed by dialing (855) 312-9420 (US/Canada toll-free) or (210) 874-7774 (International). A live webcast will also be accessible via the “Events & Presentations” section of the company’s website www.willscotmobilemini.com. An archived version of the webcast will be available for 60 days following the call.About WillScot Mobile Mini HoldingsWillScot...

COPENHAGEN, Denmark, July 06, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that it has commenced an underwritten public offering of $500,000,000 of American Depositary Shares (“ADSs”), each of which represents one ordinary share of Ascendis. All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 of ADSs at the public offering price, less the underwriting commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.J.P. Morgan Securities LLC, Morgan...

Communiqué de PresseParis, 06 juillet 202017:40 CESTBILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTEAVEC LA SOCIETE DE BOURSE GILBERT DUPONTAu titre du contrat de liquidité confié par la société ARTEFACT à la Société de Bourse Gilbert Dupont, à la date du 30 juin 2020, les moyens suivants figuraient au compte de liquidité :– Nombre d’actions : 53 163 titres– Solde en espèce du compte de liquidité : 56 968,73 €Il est rappelé que lors du dernier bilan annuel au 31 décembre 2019, les moyens suivants figuraient au compte de liquidité :– Nombre d’actions : 68 585 titres– Solde en espèce du compte de liquidité : 39 112,39 €Nos prochains rendez-vous (après bourse) :23 juillet 2020Marge brute du 1er semestre 202027 octobre 2020Résultats du 1er semestre 2020 et Marge brute du 3ème trimestre 2020FINA propos d’Artefact...

 Cash and cash equivalents at €52.2m as at June 30, 2020Daix (France), July 6, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today reported its cash position as of June 30, 2020.As of June 30, 2020, Inventiva’s cash and cash equivalents stood at €52.2 million compared to €46.9 million as of March 31, 2020 and €35.8 million as of December 31, 2019.Inventiva’s net cash flow amounted to €16.4 million in the six months ended June 30, 2020 compared to (€19.6) million in the first half of 2019. Net cash used in operating activities was (€10.7) million and (€18.7) million in the first half of 2020 and 2019, respectively. Net cash...

             Trésorerie et équivalents de trésorerie à 52,2 M€ au 30 juin 2020Daix (France), le 6 juillet 2020 – Inventiva (Euronext : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, publie aujourd’hui sa position de trésorerie au 30 juin 2020.Au 30 juin 2020, la trésorerie et les équivalents de trésorerie d’Inventiva s’élevaient à 52,2 millions d’euros contre 46,9 millions d’euros au 31 mars 2020 et 35,8 millions d’euros au 31 décembre 2019.Les flux nets de trésorerie d’Inventiva se sont établis à 16,4 millions d’euros au 30 juin 2020, contre -19,6 millions d’euros au premier semestre 2019....